NCT04417075

Brief Summary

The specific aims of the project are to develop and test a Spanish language, mobile app for smoking cessation called Impacto.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 30, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

June 4, 2020

Status Verified

June 1, 2020

Enrollment Period

5 months

First QC Date

May 30, 2020

Last Update Submit

June 3, 2020

Conditions

Keywords

Smoking CessationMobile AppAnxiety Sensitivity

Outcome Measures

Primary Outcomes (2)

  • 7-Day Point Prevalence Smoking Abstinence

    Self-reported 7-day point prevalence smoking status. Verification via carbon monoxide at end of treatment (10 weeks).

    End of treatment (Week 8)

  • Change in Smoking Rate (# cigarettes per day)

    We will assess the number of cigarettes smoking at each time point.

    Baseline and Weeks 2, 4, 6, and end of treatment (Week 8)

Secondary Outcomes (4)

  • Change in Anxiety Sensitivity

    Baseline and Weeks 2, 4, 6, and end of treatment (Week 8)

  • Change in Mood and Anxiety Symptoms

    Baseline and Weeks 2, 4, 6, and end of treatment (Week 8)

  • Daily Adherence to Use of Impacto Mobile App (Impacto Condition Only)

    Daily over the course of the 8 weeks of participant study involvement

  • User Satisfaction with the Impacto Mobile App (Impacto Condition Only) Condition Only)

    Weeks 2, 4, 6, and 8

Study Arms (2)

Impacto

EXPERIMENTAL

This is the mobile app to be developed and evaluated in this project.

Behavioral: Impacto (Mobile App)

Dejar de Fumar Asistente

ACTIVE COMPARATOR

This is the mobile app that will serve as the control condition in evaluating the efficacy of Impacto.

Behavioral: Dejar de Fumar Asistente (Mobile App)

Interventions

This is the mobile app to be developed and evaluated in this project. It is designed for Spanish-speaking, Latinx smokers with high anxiety sensitivity and will be built for the Android platform. The app will include components to address and remediate anxiety sensitivity, as well as having smoking cessation components.

Impacto

Dejar de Fumar Asistente (English version called: Quit Tracker: Stop Smoking) is a popular, free third party mobile application aimed at helping smokers quit smoking. This is the mobile app that will serve as the control condition in evaluating the efficacy of Impacto. This mobile app is well established as a smoking cessation app for Spanish-speaking, Latinx smokers. The app includes smoking cessation components but does not have a specific emphasis on anxiety sensitivity.

Dejar de Fumar Asistente

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • \) 18 to 55 year of age, 2) current smoker (i.e., at least 6 cigarettes/day), 3) not currently engaged in smoking cessation treatment, 4), high anxiety sensitivity (AS) score defined as an ASI-III score of ≥ 23, 5) motivation to quit \> 5 on a 10 pt. scale, 6) Spanish speaking, and 7) currently own an Android-compatible mobile phone.

You may not qualify if:

  • \) use of other tobacco products (including e-cigarettes), 2) current non-nicotine substance dependence and/or current or intended participation in a concurrent substance abuse treatment, 3) ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression, or 4) active suicidality (i.e., suicidal ideation, intent, and/or plan) or current psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anxiety and Health Research Laboratory and Substance Use Treatment Clinic, University of Houston

Houston, Texas, 77204, United States

RECRUITING

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Central Study Contacts

Justin M Shepherd, M.A.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Hugh Roy and Lillie Cranz Cullen Distinguished University Professor

Study Record Dates

First Submitted

May 30, 2020

First Posted

June 4, 2020

Study Start

February 21, 2020

Primary Completion

July 31, 2020

Study Completion

July 31, 2020

Last Updated

June 4, 2020

Record last verified: 2020-06

Locations